Ashland purchases manufacturing rights for Vital ET and TPM
Filed with ASX · · 2 pages · English
Avecho Biotechnology Limited on 6ix
Earlier from Avecho Biotechnology
- FDA meeting provides guidance for TPM/Oxymorphone patch
- Reinstatement to Offical Quotation
- Phosphagenics and Mylan Agree Settlement
- Suspension from Official Quotation
- Phosphagenics Arbitration Award Issued
Later from Avecho Biotechnology
- Terumo return rights to TPM/Propofol Injectable
- Injectable Portfolio Update - Products Differentiated by TPM
- Appendix 4C - Quarterly
- Appendix 4E and Annual Report 31 December 2019
- Avecho signs Term Sheet for Cannabinoid Supply with Purisys
Follow Avecho Biotechnology into a list and get an email when it puts out news.
Follow Avecho Biotechnology